We are live on ! Find out more
TSRX

TRIUS THERAPEUTICS INC COM STK (DE)
TSRX

Delisted

TSRX was delisted on the 11th of September, 2013.

Back to rankings

7 hedge funds and large institutions have $529K invested in TRIUS THERAPEUTICS INC COM STK (DE) in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 3 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% less funds holding

Funds holding: 84 → 7 (-77)

96% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 79

100% less capital invested

Capital invested by funds: $145M → $529K (-$144M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
7
Holders Change
-77
Holders Change %
-91.67%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
3
Closed
79
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Amici Capital
New York
+$5.16M
2
FCH
Freestone Capital Holdings
Washington
+$197K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$21M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$14M
3
First Eagle Investment Management
First Eagle Investment Management
New York
-$13.6M
4
BFA
BlackRock Fund Advisors
California
-$11.2M
5
UBS AM
UBS AM
Illinois
-$9.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$139K -$1.47M -119,715 -92%
LTFS
2
Ladenburg Thalmann Financial Services
Florida
$123K -$21.9K -1,775 -16%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$102K – – –
FCH
4
Freestone Capital Holdings
Washington
$93K +$197K +16,000 New
AC
5
Amici Capital
New York
$54K +$5.16M +418,700 New
FWM
6
Focused Wealth Management
New York
$18K +$15.9K +1,295 New
Manulife (Manufacturers Life Insurance)
7
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$415 -$12.5K -1,016 -3%
Wellington Management Group
8
Wellington Management Group
Massachusetts
– -$21M -2,589,356 Closed
Fidelity Investments
9
Fidelity Investments
Massachusetts
– -$14M -1,728,555 Closed
First Eagle Investment Management
10
First Eagle Investment Management
New York
– -$13.6M -1,672,487 Closed
BFA
11
BlackRock Fund Advisors
California
– -$11.2M -1,378,681 Closed
UBS AM
12
UBS AM
Illinois
– -$9.19M -1,132,270 Closed
Vanguard Group
13
Vanguard Group
Pennsylvania
– -$5.36M -659,415 Closed
HCM
14
Harvey Capital Management
Florida
– -$4.45M -549,850 Closed
BIT
15
BlackRock Institutional Trust
California
– -$3.79M -468,510 Closed
State Street
16
State Street
Massachusetts
– -$3.56M -438,104 Closed
Axa
17
Axa
France
– -$3.51M -432,496 Closed
Northern Trust
18
Northern Trust
Illinois
– -$3.49M -431,308 Closed
BC
19
Broadfin Capital
New York
– -$3.28M -404,427 Closed
Bank of America
20
Bank of America
North Carolina
– -$2.56M -315,632 Closed
Wells Fargo
21
Wells Fargo
California
– -$2.45M -302,720 Closed
Deutsche Bank
22
Deutsche Bank
Germany
– -$2.34M -288,885 Closed
BB
23
BB Biotech
Switzerland
– -$2.27M -280,000 Closed
EI
24
EAM Investors
California
– -$2.2M -270,881 Closed
TC
25
TFS Capital
Pennsylvania
– -$1.91M -235,592 Closed
1
2 3 4

TSRX Hedge Fund Activity: Q3 2013 in Review

7 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) for Q3 2013, worth a combined $529K — down 100% from $145M a quarter earlier.

Sellers outnumbered buyers: 79 funds closed out of TSRX and 3 opened new positions — a net loss of 76 holders — while 3 trimmed existing stakes and 0 added.

The largest buyer was Amici Capital, opening a new position worth an estimated $5.16M. The largest seller was Wellington Management Group, exiting entirely with an estimated $21M sold.

  • 7 institutional investors held TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) as of Q3 2013, down from 84 in Q2 2013.
  • Funds reported $529K of TRIUS THERAPEUTICS INC COM STK (DE) stock for Q3 2013, down 100% quarter-over-quarter.
  • 3 funds opened new TRIUS THERAPEUTICS INC COM STK (DE) positions in Q3 2013 and 79 closed out, a net change of -76 holders.
  • The largest TRIUS THERAPEUTICS INC COM STK (DE) buyer in Q3 2013 was Amici Capital, an estimated $5.16M added.
  • The largest TRIUS THERAPEUTICS INC COM STK (DE) seller in Q3 2013 was Wellington Management Group, an estimated $21M sold.

Based on aggregated 13F filings for Q3 2013.